The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
AKEBIA THERAPEUTICS INC COM 00972D105   14,827,684 16,205,119 SH   SOLE   16,205,119 0 0
AILERON THERAPEUTICS INC COM NEW 00887A204   1,486,534 830,466 SH   SOLE   830,466 0 0
AMERICAN WELL CORP CL A 03044L105   21,999,006 10,475,717 SH   SOLE   10,475,717 0 0
ANNEXON INC COM 03589W102   24,837,204 7,056,024 SH   SOLE   7,056,024 0 0
AADI BIOSCIENCE INC COM 00032Q104   11,154,877 1,630,830 SH   SOLE   1,630,830 0 0
ASSEMBLY BIOSCIENCES INC COM 045396108   2,561,625 2,227,500 SH   SOLE   2,227,500 0 0